Don Lehr
General Counsel bij PRECIGEN, INC.
Vermogen: 780 283 $ op 31-03-2024
Actieve functies van Don Lehr
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PRECIGEN, INC. | General Counsel | 01-01-2009 | - |
| Corporate Secretary | - | - | |
Genten Therapeutics, Inc.
 Genten Therapeutics, Inc. BiotechnologyHealth Technology Genten Therapeutics, Inc. operates as a biotechnology firm. It delivers a monotherapy through an antigen-specific induction of immune tolerance for gluten to address unmet medical need. The company is headquartered in San Francisco, CA. | Chief Executive Officer | - | - |
| Corporate Secretary | - | - |
Loopbaan van Don Lehr
Eerdere bekende functies van Don Lehr
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENVEC INC | Director/Board Member | 16-06-2017 | - |
| President | 16-06-2017 | - | |
| Treasurer | 16-06-2017 | - |
Opleiding van Don Lehr
| The Johns Hopkins University | Graduate Degree |
| Swarthmore College | Undergraduate Degree |
| The University of Maryland Francis King Carey School of Law | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Secretary | 2 |
| Graduate Degree | 2 |
| General Counsel | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Genten Therapeutics, Inc.
Genten Therapeutics, Inc. BiotechnologyHealth Technology Genten Therapeutics, Inc. operates as a biotechnology firm. It delivers a monotherapy through an antigen-specific induction of immune tolerance for gluten to address unmet medical need. The company is headquartered in San Francisco, CA. | Health Technology |
